Related Experiment Video
Updated: Jul 28, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis
Lihong Liu1, Jie Du2, Sidi Yang3
1MOE Key Laboratory of Tropical Disease Control, Centre for Infection and Immunity Study (CIIS), School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat-Sen University, Shenzhen, China; Guangzhou Laboratory, Bio-island, Guangzhou, Guangdong, PR China.
Abstract:
Viral infection-induced cell death has long been considered as a double-edged sword in the inhibition or exacerbation of viral infections. Patients with severe Coronavirus Disease 2019 (COVID-19) are characterized by multiple organ dysfunction syndrome and cytokine storm, which may result from SARS-CoV-2-induced cell death. Previous studies have observed enhanced ROS level and signs of ferroptosis in SARS-CoV-2 infected cells or specimens of patients with COVID-19, but the exact mechanism is not clear yet. Here, we find SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis. SARS-CoV-2 ORF3a promotes the degradation of NRF2 through recruiting Keap1, thereby attenuating cellular resistance to oxidative stress and facilitated cells to ferroptotic cell death. Our study uncovers that SARS-CoV-2 ORF3a functions as a positive regulator of ferroptosis, which might explain SARS-CoV-2-induced damage in multiple organs in COVID-19 patients and imply the potential of ferroptosis inhibition in COVID-19 treatment.
Insights
The SARS-CoV-2 virus
Area of Science:
- Virology
- Cellular Biology
- Immunology
Background:
- Viral infection-induced cell death impacts viral pathogenesis.
- Severe COVID-19 involves organ dysfunction and cytokine storms, potentially linked to SARS-CoV-2-induced cell death.
- Elevated reactive oxygen species (ROS) and ferroptosis signs are noted in COVID-19, but mechanisms remain unclear.
Purpose of the Study:
- To elucidate the mechanism by which SARS-CoV-2 induces cell death.
- To investigate the role of the SARS-CoV-2 ORF3a protein in cell death pathways.
- To explore the connection between SARS-CoV-2 infection, oxidative stress, and ferroptosis.
Main Methods:
- Investigated the interaction between SARS-CoV-2 ORF3a and the Keap1-NRF2 pathway.
- Assessed the impact of ORF3a on NRF2 degradation and cellular oxidative stress resistance.
- Utilized cell models to study ferroptosis induction by SARS-CoV-2 components.
Main Results:
- SARS-CoV-2 ORF3a sensitizes cells to ferroptosis.
- ORF3a promotes NRF2 degradation by recruiting Keap1, reducing cellular antioxidant defense.
- This mechanism facilitates ferroptotic cell death, contributing to viral pathogenesis.
Conclusions:
- SARS-CoV-2 ORF3a acts as a positive regulator of ferroptosis.
- This finding may explain multi-organ damage observed in COVID-19 patients.
- Inhibition of ferroptosis presents a potential therapeutic strategy for COVID-19.
More Related Videos
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
10:39Author Spotlight: Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures
Published on: April 14, 2023
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
PI3K/mTOR/AKT Signaling Pathway
The Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...